
Share
Bullseye Event in Chicago will bring together top healthcare investors and innovators for exclusive talks on digital health and AI, aiming to forge key partnerships that drive healthier outcomes and lucrative returns.
MedCity News, a leading source for healthcare innovation, is shifting gears with its new event, Bullseye: Targeting Healthier Outcomes & Returns. Scheduled for July 23 in Chicago, this invitation-only gathering is designed exclusively for healthcare investors and corporate business development leaders. The goal is to facilitate meaningful connections and explore the evolving landscape of healthcare technology, particularly in the realms of digital health and artificial intelligence.
The event marks a departure from traditional industry conferences by focusing on high-level discussions and strategic partnerships rather than startup pitches or aggressive networking. Bullseye aims to bring together key players who are shaping the future of healthcare through investment and innovation.
As new technologies continue to disrupt traditional healthcare categories, the lines between biopharma, diagnostics, and AI are blurring. Private equity firms are increasingly engaging in early-stage deals, while global investors are showing a growing interest in the American healthcare market. Established companies are also seeking competitive advantages by partnering with or acquiring innovative startups.
Bullseye addresses these trends by providing a platform for executives to engage in thoughtful conversations and relaxed networking. Attendees will include managing directors from Kaiser Permanente Ventures, partners from CVS Health Ventures, and senior directors from PSP Investments, among others. The event is designed to foster an environment where strategic partnerships can form, driven by shared goals of improving healthcare outcomes and achieving robust returns.
The organizers emphasize that Bullseye is not just another conference. There are no early-bird deadlines, no ticket discounts, and no unsolicited pitches. Instead, the focus is on creating a curated experience for full-time institutional investors and corporate business development leaders in healthcare. The event will feature a day of insightful discussions, relaxed networking, and even some healthy competition-fitting for a summer gathering in Chicago.

For investors and corporate leaders, Bullseye offers a unique opportunity to stay ahead of the curve in an increasingly competitive market. The event's exclusive nature ensures that attendees are at the forefront of healthcare innovation, with access to key decision-makers from leading institutions.
Some notable attendees include:
These professionals bring a wealth of expertise and experience to the table, making Bullseye a valuable platform for exploring new opportunities in healthcare investment. The event's focus on strategic partnerships and innovative technologies aligns with the growing trend of cross-sector collaboration in the healthcare industry.
For those interested in attending, MedCity News invites executives from venture capital firms, university endowments, family offices, pension funds, private equity funds, sovereign wealth funds, and other institutional investors focused on healthcare to join the waitlist. This boutique event promises to be a pivotal gathering for anyone looking to navigate the evolving landscape of healthcare investment and innovation.
Bullseye: Targeting Healthier Outcomes & Returns is more than just a conference; it's a strategic initiative designed to bridge the gap between investors and innovators in the healthcare sector. By fostering meaningful connections and facilitating high-level discussions, Bullseye aims to drive positive change and generate significant returns for all stakeholders involved. For healthcare professionals and investors, this event represents a crucial opportunity to stay informed, network, and position themselves at the forefront of industry trends.
Tags
Original Sources
Inviting Investors and Corporate Business Development Leaders to Bullseye - MedCity News
↗ https://medcitynews.com/2026/05/inviting-investors-and-corporate-business-development-leaders-to-bullseye
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
14 May 2026
133 articles
Related Articles
Related Articles
More Stories